|
1
|
Gerke V and Moss SE: Annexins: From
structure to function. Physiol Rev. 82:331–371. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Moss SE and Morgan RO: The annexins.
Genome Biol. 5:2192004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gerke V, Creutz CE and Moss SE: Annexins:
Linking Ca2+ signalling to membrane dynamics. Nat Rev
Mol Cell Biol. 6:449–461. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hayes MJ and Moss SE: Annexins and
disease. Biochem Biophys Res Commun. 322:1166–1170. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rescher U and Gerke V: Annexins - unique
membrane binding proteins with diverse functions. J Cell Sci.
117:2631–2639. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lecona E, Turnay J, Olmo N,
Guzmán-Aránguez A, Morgan RO, Fernandez MP and Lizarbe MA:
Structural and functional characterization of recombinant mouse
annexin A11: Influence of calcium binding. Biochem J. 373:437–449.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mussunoor S and Murray GI: The role of
annexins in tumour development and progression. J Pathol.
216:131–140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bastian BC: Annexins in cancer and
autoimmune diseases. Cell Mol Life Sci. 53:554–556. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huber R, Schneider M, Mayr I, Römisch J
and Paques EP: The calcium binding sites in human annexin V by
crystal structure analysis at 2.0 A resolution. Implications for
membrane binding and calcium channel activity. FEBS Lett.
275:15–21. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Enrich C, Rentero C, de Muga SV, Reverter
M, Mulay V, Wood P, Koese M and Grewal T: Annexin A6-Linking
Ca(2+) signaling with cholesterol transport. Biochim
Biophys Acta. 1813:935–947. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Edwards HC and Crumpton MJ:
Ca(2+)-dependent phospholipid and arachidonic acid
binding by the placental annexins VI and IV. Eur J Biochem.
198:121–129. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
deDiego I, Schwartz F, Siegfried H,
Dauterstedt P, Heeren J, Beisiegel U, Enrich C and Grewal T:
Cholesterol modulates the membrane binding and intracellular
distribution of annexin 6. J Biol Chem. 277:32187–32194. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Domon MM, Matar G, StrzeleckaKiliszek A,
BandorowiczPikula J, Pikula S and Besson F: Interaction of annexin
A6 with cholesterol rich membranes is pH-dependent and mediated by
the sterol OH. J Colloid Interface Sci. 346:436–441. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Monastyrskaya K, Tschumi F, Babiychuk EB,
Stroka D and Draeger A: Annexins sense changes in intracellular pH
during hypoxia. Biochem J. 409:65–75. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sprenger RR, Speijer D, Back JW, De Koster
CG, Pannekoek H and Horrevoets AJ: Comparative proteomics of human
endothelial cell caveolae and rafts using two-dimensional gel
electrophoresis and mass spectrometry. Electrophoresis. 25:156–172.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cubells L, Vilà de Muga S, Tebar F, Wood
P, Evans R, Ingelmo-Torres M, Calvo M, Gaus K, Pol A, Grewal T and
Enrich C: Annexin A6-induced alterations in cholesterol transport
and caveolin export from the Golgi complex. Traffic. 8:1568–1589.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hosoya H, Kobayashi R, Tsukita S and
Matsumura F: Ca(2+)-regulated actin and phospholipid
binding protein (68 kD-protein) from bovine liver: Identification
as a homologue for annexin VI and intracellular localization. Cell
Motil Cytoskeleton. 22:200–210. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Creutz CE and Snyder SL: Interactions of
annexins with the mu subunits of the clathrin assembly proteins.
Biochemistry. 44:13795–13806. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bode G, Lüken A, Kerkhoff C, Roth J,
Ludwig S and Nacken W: Interaction between S100A8/A9 and annexin A6
is involved in the calcium-induced cell surface exposition of
S100A8/A9. J Biol Chem. 283:31776–31784. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tiacci E, Orvietani PL, Bigerna B,
Pucciarini A, Corthals GL, Pettirossi V, Martelli MP, Liso A,
Benedetti R, Pacini R, et al: Tumor protein D52 (TPD52): A novel
B-cell/plasma-cell molecule with unique expression pattern and
Ca(2+)-dependent association with annexin VI. Blood.
105:2812–2820. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chow A, Davis AJ and Gawler DJ:
Identification of a novel protein complex containing annexin VI,
Fyn, Pyk2, and the p120(GAP) C2 domain. FEBS Lett. 469:88–92. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Grewal T, Koese M, Rentero C and Enrich C:
Annexin A6-regulator of the EGFR/Ras signalling pathway and
cholesterol homeostasis. Int J Biochem Cell Biol. 42:580–584. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koese M, Rentero C, Kota BP, Hoque M,
Cairns R, Wood P, Vilà de Muga S, Reverter M, Alvarez-Guaita A,
Monastyrskaya K, et al: Annexin A6 is a scaffold for PKCα to
promote EGFR inactivation. Oncogene. 32:2858–2872. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Z, Tung PS and Moran MF: Association
of p120 ras GAP with endocytic components and colocalization with
epidermal growth factor (EGF) receptor in response to EGF
stimulation. Cell Growth Differ. 7:123–133. 1996.PubMed/NCBI
|
|
25
|
Lomnytska MI, Becker S, Hellman K,
Hellström AC, Souchelnytskyi S, Mints M, Hellman U, Andersson S and
Auer G: Diagnostic protein marker patterns in squamous cervical
cancer. Proteomics Clin Appl. 4:17–31. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Francia G, Mitchell SD, Moss SE, Hanby AM,
Marshall JF and Hart IR: Identification by differential display of
annexin-VI, a gene differentially expressed during melanoma
progression. Cancer Res. 56:3855–3858. 1996.PubMed/NCBI
|
|
27
|
Theobald J, Smith PD, Jacob SM and Moss
SE: Expression of annexin VI in A431 carcinoma cells suppresses
proliferation: A possible role for annexin VI in cell growth
regulation. Biochim Biophys Acta. 1223:383–390. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vilá de Muga S, Timpson P, Cubells L,
Evans R, Hayes TE, Rentero C, Hegemann A, Reverter M, Leschner J,
Pol A, et al: Annexin A6 inhibits Ras signalling in breast cancer
cells. Oncogene. 28:363–377. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Theobald J, Hanby A, Patel K and Moss SE:
Annexin VI has tumour-suppressor activity in human A431 squamous
epithelial carcinoma cells. Br J Cancer. 71:786–788. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Zhang S, Zhang J, Lam E, Liu X,
Sun J, Feng L, Lu H, Yu J and Jin H: Annexin A6 is down-regulated
through promoter methylation in gastric cancer. Am J Transl Res.
5:555–562. 2013.PubMed/NCBI
|
|
31
|
Grewal T, Evans R, Rentero C, Tebar F,
Cubells L, de Diego I, Kirchhoff MF, Hughes WE, Heeren J, Rye KA,
et al: Annexin A6 stimulates the membrane recruitment of p120GAP to
modulate Ras and Raf-1 activity. Oncogene. 24:5809–5820. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xin W, Rhodes DR, Ingold C, Chinnaiyan AM
and Rubin MA: Dysregulation of the annexin family protein family is
associated with prostate cancer progression. Am J Pathol.
162:255–261. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Smith DL, Evans CA, Pierce A, Gaskell SJ
and Whetton AD: Changes in the proteome associated with the action
of Bcr-Abl tyrosine kinase are not related to transcriptional
regulation. Mol Cell Proteomics. 1:876–884. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sakwe AM, Koumangoye R, Guillory B and
Ochieng J: Annexin A6 contributes to the invasiveness of breast
carcinoma cells by influencing the organization and localization of
functional focal adhesions. Exp Cell Res. 317:823–837. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Koumangoye RB, Nangami GN, Thompson PD,
Agboto VK, Ochieng J and Sakwe AM: Reduced annexin A6 expression
promotes the degradation of activated epidermal growth factor
receptor and sensitizes invasive breast cancer cells to
EGFR-targeted tyrosine kinase inhibitors. Mol Cancer. 12:1672013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen JS, CoustanSmith E, Suzuki T, Neale
GA, Mihara K, Pui CH and Campana D: Identification of novel markers
for monitoring minimal residual disease in acute lymphoblastic
leukemia. Blood. 97:2115–2120. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tressler RJ, Yeatman T and Nicolson GL:
Extracellular annexin VI expression is associated with divalent
cation-dependent endothelial cell adhesion of metastatic RAW117
large-cell lymphoma cells. Exp Cell Res. 215:395–400. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jerant AF, Johnson JT, Sheridan CD and
Caffrey TJ: Early detection and treatment of skin cancer. Am Fam
Physician. 62:357–368, 375–376, 381–382. 2000.PubMed/NCBI
|
|
39
|
Arbyn M, Castellsagué X, de Sanjosé S,
Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of
cervical cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lomnytska MI, Becker S, Bodin I, Olsson A,
Hellman K, Hellström AC, Mints M, Hellman U, Auer G and Andersson
S: Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4
during uterine cervix carcinogenesis: Diagnostic and prognostic
value. Br J Cancer. 104:110–119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
King IC and Sartorelli AC: The
relationship between epidermal growth factor receptors and the
terminal differentiation of A431 carcinoma cells. Biochem Biophys
Res Commun. 140:837–843. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sakwe AM, Koumangoye R, Goodwin SJ and
Ochieng J: Fetuin-A ({alpha}2HS-glycoprotein) is a major serum
adhesive protein that mediates growth signaling in breast tumor
cells. J Biol Chem. 285:41827–41835. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kundranda MN, Ray S, Saria M, Friedman D,
Matrisian LM, Lukyanov P and Ochieng J: Annexins expressed on the
cell surface serve as receptors for adhesion to immobilized
fetuin-A. Biochim Biophys Acta. 1693:111–123. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pierce A, OwenLynch PJ, Spooncer E, Dexter
TM and Whetton AD: p210 Bcr-Abl expression in a primitive
multipotent haematopoietic cell line models the development of
chronic myeloid leukaemia. Oncogene. 17:667–672. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shehata M, Bièche I, Boutros R,
Weidenhofer J, Fanayan S, Spalding L, Zeps N, Byth K, Bright RK,
Lidereau R and Byrne JA: Nonredundant functions for tumor protein
D52-like proteins support specific targeting of TPD52. Clin Cancer
Res. 14:5050–5060. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Rubin MA, Varambally S, Beroukhim R,
Tomlins SA, Rhodes DR, Paris PL, Hofer MD, StorzSchweizer M, Kuefer
R, Fletcher JA, et al: Overexpression, amplification, and androgen
regulation of TPD52 in prostate cancer. Cancer Res. 64:3814–3822.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Byrne JA, Balleine RL, Schoenberg Fejzo M,
Mercieca J, Chiew YE, Livnat Y, St Heaps L, Peters GB, Byth K,
Karlan BY, et al: Tumor protein D52 (TPD52) is overexpressed and a
gene amplification target in ovarian cancer. Int J Cancer.
117:1049–1054. 2005. View Article : Google Scholar : PubMed/NCBI
|
